(Reuters) - Activist investor William Ackman said on Tuesday he supports the $66 billion deal in which Actavis PLC will buy Allergan Inc and will withdraw his request for an Allergan special shareholder meeting.
Ackman, who had been fighting alongside Valeant Pharmaceuticals International Inc for control of ALLERGAN (AGN.NY) had called for the Allergan meeting to vote out board members and force the company to the table to consider their joint offer. The meeting is scheduled for Dec. 18.
"We congratulate Actavis and Allergan on their announced transaction. As a result of the deal, we are withdrawing our special meeting request," Ackman said in an e-mailed statement.
Ackman's comments come after Actavis said on Monday it would pay $219 per share for Allergan, billions more than Valeant was willing to pay. Ackman, who owns nearly 10 percent of Allergan, had paper gains of more than $2.3 billion based on that price.
CNBC reported earlier that Ackman will meet with executives from Actavis later this week.
(Reporting by Caroline Humer; editing by Gunna Dickson)
Relacionados
- Bahréin y Emiratos se retractan de su retirada del Mundial de balonmano
- El BNG localiza una docena de símbolos franquistas en Vigo, Baiona y Nigrán y exige su retirada inmediata
- El presidente de Rumanía pide la retirada del proyecto de ley de amnistía para los corruptos
- El Parlamento pide la retirada de la Medalla de Oro a Huarte y Urmeneta y que se conceda a los asesinados del franquismo
- Extrem Puro Extremadura reclama a McDonald's la retirada del nombre 'Extrem' de sus hamburguesas